Search

everythinglearnresearchcommunity

for

Search:↓

The report found a new type of hair loss in African-American women that affects more areas of the scalp than previously thought.

CCCA affects Black men too, with a genetic link found in the PADI3 gene.

CCCA can affect both genders and all ages, and it has a genetic component.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

DPCP alone is more effective and safer for treating chronic extensive alopecia areata than combining it with anthralin.

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

AUC and APL are distinct conditions needing careful clinical assessment.

AP collagen peptides may help hair grow better and become stronger.

Diphenylcyclopropenone (DPCP) is effective in treating alopecia areata, with most patients showing significant hair regrowth.

Treatment improved scalp conditions and hair loss with no recurrence after 1 year.

A scale was made to measure hair loss severity in African American women.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

AP collagen peptides help hair grow and improve hair health.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

CCCA is a common scarring hair loss in African descent women, possibly linked to genetics, hair care practices, and health issues like diabetes.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Hair shaft changes may be linked to CCCA, but their role is unclear.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Fibrosing alopecia in a pattern distribution is a new type of scarring hair loss that resembles common baldness and an autoimmune skin disease.

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

AcD scaffolds improve tissue repair and regeneration by combining stem cells with a supportive matrix.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.